The next trough in oil prices could come just as OPEC members gather in Algeria next month – and that could make for an interesting, and more unpredictable outcome.
The yuan's moves have become far less worrisome for markets even though it may take a while for investors to become more confident in China.
Prolonged low rates and dwindling liquidity for loans on the secondary market could grind home sales to a halt again.
Active managers serve a powerful social function, according to a Bernstein strategist. But does that make active investors akin to philanthropists?
If the U.S. presidential election were held today, Hillary Clinton would have a 95 percent chance of beating Donald Trump.
Republican presidential candidate Donald Trump threatened to slap tariffs on Chinese products.
Heather Bresch is the daughter of a U.S. senator, incorporated her American company in the Netherlands and got an MBA she wasn't entitled to.
Aided by both Sears' demise and booming housing market, the growing appliance category hasn't gotten too crowded — yet.
A giant pot of corporate gold sits outside the United States, and the Treasury and the European Commission are squabbling over how to get it
The bear case for stocks will soon be losing backers as a pickup in earnings and optimistic economic projections could take stocks to new highs.
Shares of gold miners fell as gold dropped below its 50-day moving average, ahead of Yellen's highly anticipated Friday speech.
Most HealthCare.gov customers could buy health plans for under $100 per month next year even if prices grew by 25 percent.
The market is trading in a narrow range, but there is opportunity to make higher returns if investors know where to look, two experts say.
Investors have enjoyed a very favorable risk-reward relationship in U.S. stocks recently, but what will the future bring? Max Wolff of Manhattan Venture Partners and Erin Gibbs of S&P Global discuss with Brian Sullivan.
Hillary Clinton called on pharmaceutical company Mylan to voluntarily drop the price of their severe allergy treatment drug EpiPen.
Earlier the iShares NASDAQ Biotechnology ETF (IBB) gained about 1 percent, but reversed its course after Clinton's tweet.
CNBC's Rick Santelli and Lindsey Group's Peter Boockvar discuss why government programs continue to fail.
Global youth unemployment will rise in 2016 for the first time in three years, the International Labour Organization forecast on Wednesday.
CNBC's Aditi Roy takes a look at why some students are ditching college or grad school and choosing coding classes instead.